🏛️ Verified NIH Record • Updated 2026-08-11

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care (NCT06693531)

A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of Care

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Regeneron Pharmaceuticals

🩺 Plain-English Summary (8th-Grade Level)

This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE signs and/or symptoms, eg, how difficult it is to swallow * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How EoE symptoms have changed throughout the study

Who can join: Review the eligibility criteria below.

Location: Phoenix Childrens Hospital — Phoenix, Arizona

Age range: 1 Year

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (54 Sites)

Showing the first 25 of 54 sites.

  • Phoenix Childrens Hospital — Phoenix, Arizona
  • Arizona Digestive Health/GI Alliance — Sun City, Arizona
  • Arkansas Childrens Hospital — Little Rock, Arkansas
  • Scripps Clinic — La Jolla, California
  • University of California Los Angeles (UCLA) — Los Angeles, California
  • University of Southern California Keck School of Medicine — Los Angeles, California
  • University of California, San Francisco — Oakland, California
  • Stanford University — Palo Alto, California
  • University of California San Francisco (UCSF) — San Francisco, California
  • Childrens Hospital Colorado — Aurora, Colorado
  • University of Colorado Anschutz Medical Campus — Aurora, Colorado
  • Rocky Mountain Gastroenterology — Littleton, Colorado
  • UConn Health - The Carole and Ray Neag Comprehensive Cancer Center — Farmington, Connecticut
  • Yale School of Medicine — New Haven, Connecticut
  • Gastroenterology of Greater Orlando — Orange City, Florida
  • Orlando Health — Orlando, Florida
  • Emory Healthcare, Emory Clinic — Atlanta, Georgia
  • GI Care for Kids LLC — Atlanta, Georgia
  • Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois
  • Northwestern University, Feinberg School of Medicine — Chicago, Illinois
  • Comprehensive Gastrointestinal Health, LLC — Libertyville, Illinois
  • Endeavor Health, Skokie Campus — Skokie, Illinois
  • Kansas Gastroenterology LLC — Wichita, Kansas
  • Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky
  • Boston Specialists, Chinatown Office — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗